Document is current

Article History

Received: 30 June 2024

Accepted: 3 December 2024

First Online: 18 December 2024

Declarations

:

: This gap analysis process was implemented based on the collected data in one of the stages of a larger study that had been endorsed by the Iranian Registry of Clinical Trials (approval number: IRCT20171213037859N1) and institutional level Medical Ethics Board of Trustees (MEBoT) affiliated to the Tabriz University of Medical Sciences (approval number: IR.TBZMED.REC.1397.425). Since, no human subjects were enrolled in this phase of the study, it was sought exempt from obtaining re-application for ethical approval.

: The authors declare no competing interests.